Changes in the prevalence, Incidence and residual risk for HIV and hepatitis C virus in southern brazilian blood donors since the implementation of NAT screening

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 47, Issue 4, 2014, Pages 418-425

  Kupek, Emil ^a   Petry, Andrea ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Centro de Hematologia e Hemoterapia de Santa Catarina   (Brazil)

Author keywords

Blood donors; HCV; HIV; Incidence; Prevalence; Residual risk

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; BRAZIL; CLINICAL EXAMINATION; EDUCATION; FEMALE; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION; RACE; SEROPREVALENCE; SEXUAL BEHAVIOR; SYPHILIS; YOUNG ADULT; COMPARATIVE STUDY; HEPATITIS C; HIV INFECTIONS; MASS SCREENING; PREVALENCE; PROCEDURES; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; BRAZIL; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84907194853     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0133-2014     Document Type: Article

References (26)

1. Maresch C, Schluter PJ, Wilson AD, Sleigh A. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil. Transfusion 2008; 48:273-281.
2. Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2012; 102:82-90.
3. Canutti Júnior V. Risco transfusional: Metodologia e estudo. Atualização em Hemoterapia 1998; 5:90-99.
4. Covas DT. Risco de transmissão do HIV-1 pelas transfusões de sangue. Atualização em Hemoterapia 1998; 5:100-106.
5. Kupek EJ. Residual transfusion risk for hepatitis B and C in southern Brazil, 1991-1999. J Viral Hepat 2001; 8:89-82.
6. Kupek EJ. The redution of HIV reduction of HIV transfusion risk in southern Brazil in the 1990s. Transfusion Med 2001; 11:75-78.
7. Kupek E. Transfusion risk for hepatitis B, hepatitis C and HIV in the state of Santa Catarina, Brazil, 1991-2001. Braz J Infect Dis 2004; 8:236-240.
8. Barreto CC, Sabino EC, Gonçales TT, Laycock ME, Pappalardo BL, Salles NA, et al. Prevalence, incidence, and residual risk of human immunodefi ciency virus community and replacement first-time blood donors in São Paulo, Brazil. Transfusion 2005; 45:1709-1714.
9. Spada C, Souza MA, Treitinger A. Estimation of the Residual Risk for the Transmission of HIV in Blood Donors from the Mountain region of Santa Catarina. Braz J Infect Dis 2005; 9:489-493.
10. Sabino EC, Gonçalez TT, Carneiro-Proietti AB, Sarr M, Ferreira JE, Sampaio DA, et al. Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil. Transfusion 2012; 52:870-879.
11. Pinto AR, Petry A, Graef T, Vandresen R, Kupek EJ. Case report of haemovigilance investigation using phylogenetic analysis of HIV-1 in Brazil. Transfus Med 2012; 22:57-62.
12. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. NEJM 1996; 334:1685-1690.
13. Goncalez TT, Sabino EC, Murphy EL, Chen S, Chamone DA, McFarland W. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil. Vox Sang 2006; 90:170-176.
14. Zou S, Fang CT, Dodd RY. A method for estimating incidence rate of infectious diseases among first-time blood doors. Transfusion 2008; 48:1827-1832.
15. Fonseca MG, Bastos FI. Twenty-five years of the AIDS epidemic in Brazil: principal epidemiological findings, 1980-2005. Cad Saude Publica 2007; 23 (supl III): S333-S344.
16. Rosini N, Mousse D, Spada C, Treitinger A. Seroprevalence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001. Braz J Infect Dis 2003; 7:262-267.
17. Almeida-Neto C, Sabino EC, Liu J, Blatyta PF, Mendrone-Junior A, Salles NA, et al. Prevalence of serological markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus. Transfusion 2013; 53:827-834.
18. Bruhn R, Lelie N, Custer B, Busch M, Kleinman S, International NAT Study Group. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios. Transfusion 2013; 53:2399-2412.
19. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, et al. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009; 49:1115-1125.
20. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, et al. Trends in incidence and prevalence of major transfusiontransmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284:229-235.
21. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42:975-979.
22. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003; 169:767-773.
23. Seed CR, Kiely P, Keller AJ. Residual risk of transfusion transmitted human immunodefi ciency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Intern Med J 2005; 35:592-598.
24. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45:254-264.
25. Pillonel J, Le Marrec N, Girault A, David D, Laperche S. Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003. Transfus Clin Biol 2005;12:239-246.
26. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50:1495-1504.